Download
1 / 6
60 likes | 375 Vues
This report gives thorough data on the helpful advancement for Psoriatic Arthritis, complete with relative investigation at different stages, therapeutics evaluation by medication target, component of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and included news and press discharges. It additionally audits key players included in the restorative advancement for Psoriatic Arthritis and extraordinary elements on late-stage and stopped undertakings. <br>The report upgrades choice making capacities and help to make powerful counter methodologies to increase game changer. It fortifies R&D pipelines by distinguishing new targets and MOAs to create first-in-class and best-in-class items.<br>
E N D
Psoriatic Arthritis - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Market Direct Date: 29-May-2015 No. of pages: 190 Single User License: US $2000 Browse more Reports on Arthritis Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/arthritis-therapeutics . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Psoriatic Arthritis - Pipeline Review, H1 2015 This report gives thorough data on the helpful advancement for Psoriatic Arthritis, complete with relative investigation at different stages, therapeutics evaluation by medication target, component of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and included news and press discharges. It additionally audits key players included in the restorative advancement for Psoriatic Arthritis and extraordinary elements on late-stage and stopped undertakings. The report upgrades choice making capacities and help to make powerful counter methodologies to increase game changer. It fortifies R&D pipelines by distinguishing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Psoriatic Arthritis - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : AbbVie Inc., AbGenomics International, Inc., Alder Biopharmaceuticals Inc., Amgen Inc., Avesthagen Limited, Biocon Limited, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Inc., CoherusBioSciences, Inc., Covagen AG, Eli Lilly and Company, Epirus Biopharmaceuticals, Inc., GenorBioPharma Co., Ltd., Inbiopro Solutions Pvt. Ltd., Innovent Biologics, Inc., Johnson & Johnson, Kineta, Inc., Mabion SA, Momenta Pharmaceuticals, Inc., Novartis AG, Oncobiologics, Inc., Panacea Biotec Limited, Pfizer Inc., Sandoz International GmbH, Swedish Orphan Biovitrum AB, Therapeutic Proteins International, LLC and UCB S.A. Drugs Profile Discussed in this Research : abatacept (recombinant), AbGn-168H, ABT-122, adalimumab biosimilar, anakinra (recombinant) , apremilast, bimekizumab, brodalumab, clazakizumab, COVA-322, dalazatide, etanercept biosimilar, golimumab, golimumab biosimilar, guselkumab, IBI-303, IBPM-004AM, IBPM-005IX, infliximab biosimilar, INV-17, itolizumab, ixekizumab, Peptide to Inhibit CD44 for Rheumatoid and Psoriatic Arthritis, secukinumab and tofacitinib. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Psoriatic Arthritis - Pipeline Review, H1 2015 Scope For Psoriatic Arthritis - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Psoriatic Arthritis • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Psoriatic Arthritis and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Psoriatic Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Psoriatic Arthritis - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Psoriatic Arthritis • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Psoriatic Arthritis pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Psoriatic Arthritis - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
